Nearly 2 million people took action to oppose the Food and Drug Administration’s approval of a genetically engineered fish for human consumption. Unfortunately, the agency ignored these comments. Now we’re in court.
We’re challenging this decision in court, and we need your help!
Make an urgent tax-deductible gift to help us see this—and other critical fights—through.
Not only will the FDA not require that these GE salmon be labeled to let consumers know what they’re buying, but it also failed to analyze and prevent the risks to wild salmon and the environment.
The fish in question are the spawn of a company called AquaBounty Technologies and are engineered in laboratories to grow twice as fast as wild salmon.
AquaBounty plans to produce the GE salmon eggs on Prince Edward Island, Canada, and send the salmon on a 5,000-mile journey before they reach U.S. supermarkets.
The salmon will be grown to market size in a facility in Panama, processed into fillets, then shipped to the United States for sale. That complicated scheme is only for the initial approval, however.
AquaBounty has publicly announced plans to ultimately grow its GE fish in the United States and other places around the world. Despite this, the FDA has chosen to limit the scope of its review to the Canada and Panama facilities.
U.S. Atlantic salmon, and many populations of Pacific salmon, are protected by the Endangered Species Act and in danger of extinction. A keystone species, salmon have unique runs that have been treasured by human cultures for thousands of years.
But the FDA has failed to study and prevent impacts to these imperiled salmon runs should GE salmon escape or be accidentally released into the environment.
Not only can these engineered salmon crossbreed with wild native fish, they can also threaten wild populations by out-competing them for scarce resources and habitat, or by introducing new diseases.
Help us fight back!
The time to analyze and prevent those risks is now, before introducing GE salmon.
In addition to challenging the agency’s failure to consider these broader impacts, our lawsuit challenges the FDA’s claim that it has exclusive authority to approve and regulate GE animals as “animal drugs” under the 1938 Federal Food, Drug and Cosmetic Act. This law was meant to ensure the safety of veterinary drugs administered to treat disease in livestock, such as antibiotics used by farmers in pigs or chickens. The law was never intended to oversee GE animals that can pass along their altered genes to the next generation.
The FDA’s move sets a dangerous precedent for the future of our food. We can’t let this happen! Now more than ever, we need your help to stand up to powerful companies and fix our broken food system.
Make an urgent tax-deductible gift today to help us fight back to protect native fish, consumers and the wild.